Neoadjuvant systemic therapy for breast cancer: the Westmead experience

ConclusionpCR in either the breast or axilla was most likely to be achieved in patients with HER2‐positive or triple‐negative breast cancers. In patients with luminal cancers, the goal of NAST is best considered to facilitate surgical options rather than obtaining a pCR.

Source: ANZ Journal of Surgery - September 18, 2017 Category: Surgery Authors: Annelise M. Cocco, David Messer, Alexander Brown, Nina Sriram, Jenny Gilchrist, Loma Al ‐Mansouri, Richard Kefford, Farid Meybodi, James French, Jeremy Hsu, Elisabeth Elder Tags: Original Article Source Type: research